期刊文献+

阿托伐他汀对血脂异常兔血清和脂肪细胞分泌肿瘤坏死因子-α的影响 被引量:2

The influences of atorvastatin on levels of tumor necrosis factor-alpha in serum and secreted by adipocytes in hypercholesterolemic rabbits
下载PDF
导出
摘要 目的观察阿托伐他汀干预对血脂异常兔血清及脂肪细胞分泌肿瘤坏死因子-α(TNF-α)的影响,并探讨其可能机制。方法10只新西兰大白兔给予高胆固醇饮食饲养8周后,随机分为高胆固醇组和阿托伐他汀组,每组5只。另选普通饮食12周兔5只作为对照组。12周末,取腹股沟皮下脂肪组织行脂肪细胞培养,酶联免疫吸附法检测血清及脂肪细胞培养液中TNF-α水平。半定量逆转录聚合酶链反应测定脂肪细胞TNF-αmRNA的表达。结果阿托伐他汀干预4周能明显降低血脂异常兔血清总胆固醇、低密度脂蛋白胆固醇、TNF-α水平和脂肪细胞TNF-αmRNA表达量(P<0.05)。阿托伐他汀呈剂量依赖性降低脂肪细胞TNF-α表达和分泌。结论阿托伐他汀降低血脂异常兔血清TNF-α水平,其机制可能与其调脂及抑制脂肪细胞TNF-α的分泌有关。 Objective To evaluate the effect of atorvastatin on serum TNF-α concentration and TNF-α secretion of adipocytes in hypereholesterolemic rabbits. Methods Ten male New Zealand white rabbits were fed with high-cholesterol diet for 8 weeks, and were randomly divided into high cholesterol group and atorvastatin group, the control group was fed with normal diet for 12 weeks. Subcutaneous adipose tissue was collected for adipocyte culture. TNF-α concentrations in serum and adipocyte culture supematant were measured by ELISA. TNF-α mRNA expression in adipocytes was evaluated by semi-quantitative reverse transcription-polymerase chain reaction. Results Atorvastatin intervention significantly decreased serum total cholesterol, low density lipoprotein cholesterol, TNF-α levels and TNF-α expression in adipocytes in atorvastatin group compared with high cholesterol group ( P 〈 0.05). Additionally, atorvastatin inhibited the TNF-α expression and TNF-α secretion in adipocytes in dose-dependent manner( P 〈 0.05). Conclusions The results indicated that atorvastatin reduced the serum TNF-α levels in hypereholesterolemic rabbits, which may be related to its hypolipidemic effect and inhibiting effect on TNF-α secretion in adipocytes.
作者 吴洁 韦兵
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2006年第8期560-563,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 高脂血症 脂细胞 肿瘤坏死因子Α 胆固醇 阿托伐他汀 hyperlipidemia adipocytes tumor necrosis factor-alpha cholesterol atorvastatin
  • 相关文献

参考文献11

  • 1Fujiwara N, Kobayashi K. Macrophages in inflammation[J]. Curr Drug Targets Inflamm Allergy, 2005,4: 281-286.
  • 2Elkind MS, Cheng J, Beden-Albala B, et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis[J]. Stroke,2002, 33: 31-37.
  • 3Kleemann R, Princen HM, Emeis JJ, et al. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol lowering effect in APOE32 Leiden transgenic mice : evidence for antiinflammatory effects of rosuvastatin [ J ]. Circulation,2003,108: 1368-1374.
  • 4Winkler G, Kiss S, Keszthelyi L, et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha,soluble serum TNF-receptor-2 concentrations and C-peptide level[ J ].Eur J Endocrinol, 2003, 149: 129-135.
  • 5赵水平,吴洁,许竹梅,李全忠,李洁琪.非诺贝特对高胆固醇血症兔脂肪细胞摄取及降解氧化型低密度脂蛋白的影响[J].中华内分泌代谢杂志,2005,21(2):150-154. 被引量:6
  • 6Kim JK, Kim DH, Kim HG, et al. Inhibition of tumor necrosis factor-alpha-induced expression of adhesion molecules in human endothelial cells by the saponins derived from roots of Platycodon grandiflorum [J]. Toxicol Appl Pharmacol, 2006, 210:150-156.
  • 7Ono H, Ichiki T, Fukuyama K, et al. cAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular smooth muscle cell migration [ J ]. Arterioscler Thmmb Vasc Biol,2004,24:1634-1639.
  • 8Hart SN, Leka LS, Hchtenstein All, et al. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia[J]. J Lipid Res, 2002, 43:445-452.
  • 9Bullo M, Garcia-Lorda P, Megias I, et al. Systemic inflammation,adipose tissue tumor necrosis factor, and leptin expression[J]. Obes Res, 2003,11 : 525-531.
  • 10Waehre T, Damas JK, Gullestad L, et al. Hydroxymethylglutaryl coenzyme A reductase inhibitors downregulate chemokines and chemokine receptors in patients with coronary artery disease[J]. J Am Coll Cardiol, 2003, 41 : 1460-1467.

二级参考文献15

  • 1Abumrad NA, el-Maghrabi MR, Amri EZ, et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem, 1993,268:17665-17668.
  • 2Tontonoz P, Nagy L, Alvarez JG, et al. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 1998,93:241-252.
  • 3Pineda Torra I, Gervois P, Staels B. Peroxisome proliferator-activated receptor α in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol, 1999,10:151-159.
  • 4Cabrero A, Alegret M, Sanchez RM, et al. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes, 2001,50:1883-1890.
  • 5Rodbell M. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem, 1963,239:375-380.
  • 6Salacinski PR, Mclean C, Sykes JE, et al. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha, 6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem, 1981,117:136-146.
  • 7Ohgami N, Nagai R, Ikemoto M, et al. CD36, a member of the class B scavenger receptor family as a receptor for advanced glycation end products. J Biol Chem, 2001,276:3195-3202.
  • 8Van Berkel TJC, De Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density lipoprotein and AcLDL in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem, 1991:266:2282-2289.
  • 9Janabi M, Yamashita S, Hirano K, et al. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol, 2000,20:1953-1960.
  • 10Kuniyasu A, Hayashi S, Nakayama H. Adipocytes recognize and degrade oxidized low density lipoprotein through CD36. Biochem Biophys Res Commun, 2002,295:319-323.

共引文献5

同被引文献7

  • 1Dennis K Leel, Susan R George. Unravelling the roles of the Apelin system: prospective therapeutic applications in heart failure and obesity[J]. Pharmacological Sciences,2006;27(4): 190-194.
  • 2Murphy NF, Maclntyre K, Stewart S, et al. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study)[J]. Eur Heart J, 2006;27:96-106.
  • 3Eavie CJ,Milani RV, Obesity and heart failure prognosis:paradox or reverse epidemiology[J]?European Heart Journal,2005 ;26:5-7.
  • 4Daviaud D,Boucher J,Gesta S, et al. TNF-a up regulates Apelin expression inhuman and mouse adipose tissue [J]. The FASEB J,2006;20(9) : 1528-1530.
  • 5Wei L,Hou X,Tatemoto K. Regulation ofApelin mRNA expression by insulin and glucocorti coids in mouse 3T3-LI adipocytes[J]. Regul Pept,2005;130 (1,2):27-32.
  • 6Susan Kralisch, Ulrike Lossner. Growth hormone induces Apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes[J].Regul Pept,2007; 139:84-89.
  • 7DING Chao,FU Xiang-hua,HE Zhen-shan,CHEN Hui-xiao,XUE Ling,LI Jun-xia.Cardioprotective effects of simvastatin on reversing electrical remodeling induced by myocardial ischemia-reperfusion in normocholesterolemic rabbits[J].Chinese Medical Journal,2008(6):551-556. 被引量:26

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部